ImStem Biotechnology Overview
- Year Founded
-
2012

- Status
-
Private
- Employees
-
19

- Latest Deal Type
-
2ndary - Private
ImStem Biotechnology General Information
Description
Developer of a stem cell technology designed to remodel health and lifespan. The company's technology is derived from mesenchymal stem cells that have a strong anti-inflammatory activity and offer treatments for a variety of diseases caused by damage to cells, tissues, and organs, enabling doctors to focus on tissue repair, treatment of neural, heart, vascular, blood system diseases, autoimmune diseases, degenerative, and rare diseases.
Contact Information
Website
www.imstem.comCorporate Office
- 400 Farmington Avenue R1808
- Call Box 111
- Farmington, CT 06032
- United States
Corporate Office
- 400 Farmington Avenue R1808
- Call Box 111
- Farmington, CT 06032
- United States
ImStem Biotechnology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
4. Debt - General | 07-Nov-2013 | Completed | Clinical Trials - General | |||
3. Seed Round | 10-Oct-2013 | Completed | Clinical Trials - General | |||
2. Grant | 10-Jun-2013 | $1.13M | Completed | Clinical Trials - General | ||
1. Accelerator/Incubator | Completed | Startup |
ImStem Biotechnology Comparisons
Industry
Financing
Details
ImStem Biotechnology Competitors (16)
One of ImStem Biotechnology’s 16 competitors is Ona Therapeutics, a Venture Capital-Backed company based in Barcelona, Spain.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
Loxo Oncology | Formerly VC-backed | Stamford, CT | ||||
Cardurion | Venture Capital-Backed | Burlington, MA | ||||
Aspen Neuroscience | Venture Capital-Backed | San Diego, CA | ||||
Volastra | Venture Capital-Backed | New York, NY |
ImStem Biotechnology Patents
ImStem Biotechnology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2876512-A1 | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof | Active | 11-Jul-2012 | ||
US-20170290864-A1 | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof | Active | 11-Jul-2012 | ||
US-20150191699-A1 | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof | Active | 11-Jul-2012 | ||
US-10842826-B2 | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof | Active | 11-Jul-2012 | ||
US-9725698-B2 | Trophoblast-derived mesenchymal stem cells (t-mscs) produced from human embryonic stem cells, methods and uses thereof | Active | 11-Jul-2012 | A61K35/545 |
ImStem Biotechnology Signals
ImStem Biotechnology FAQs
-
When was ImStem Biotechnology founded?
ImStem Biotechnology was founded in 2012.
-
Where is ImStem Biotechnology headquartered?
ImStem Biotechnology is headquartered in Farmington, CT.
-
What is the size of ImStem Biotechnology?
ImStem Biotechnology has 19 total employees.
-
What industry is ImStem Biotechnology in?
ImStem Biotechnology’s primary industry is Drug Discovery.
-
Is ImStem Biotechnology a private or public company?
ImStem Biotechnology is a Private company.
-
What is ImStem Biotechnology’s current revenue?
The current revenue for ImStem Biotechnology is
. -
How much funding has ImStem Biotechnology raised over time?
ImStem Biotechnology has raised $260K.
-
Who are ImStem Biotechnology’s competitors?
Ona Therapeutics, Loxo Oncology, Cardurion, Aspen Neuroscience, and Volastra are some of the 16 competitors of ImStem Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »